drugset / Trial / NCT01245322

Treatment of Bacterial Vaginosis Combined With Human Lactobacilli

NCT01245322

NaSingle-groupOpen-labelTreatment

Summary

The primary objectives of this study were to characterize lactobacilli of human vaginal origin and to investigate if more extended antibiotic treatment against Bacterial Vaginosis, together with adjuvant lactobacilli treatment, could increase the cure rate and furthermore, to investigate factors that could influence relapse.

Timeline

Start
2007-01
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clindamycin Unknown 2 % Other
Comparator Clindamycin Unknown 300 mg Other
Comparator lactobacilli Unknown 1e+09 cells Other

Indications